Here are relevant reports on : academic-integrity-market
-
AI Detector Market by Offering (Platform, API/SDKs), Detection Modality (AI Generated Text, Image, Video, Voice, Code), Application (Academic Integrity, Plagiarism Detection, Deepfake Detection, Content Authenticity Assessment) - Global Forecast to 2030
The AI detector market is undergoing rapid expansion, with estimates projecting a substantial market surge from approximately USD 0.58 billion in 2025 to USD 2.06 billion by 2030, at a CAGR of 28.8%. Some major players in the AI detector market include: GPTZero (US), Originality.AI (Canada), Copyleaks (US), Turnitin (US), Writer.com (US), Smodin (US), Hive Moderation (US), Truepic (US), BrandWell AI (US), QuillBot (US), Scribbr (Netherlands), Grammarly (US), Surfer (Poland), Winston AI (Canada), AI Detector Pro (AIDP) (US), Illuminarty (US), DuckDuckGoose (Netherlands), Crossplag (US), ZeroGPT (US), Sapling.ai (US), TraceGPT (PlagiarismCheck.org) (UK), Pangram Labs (US), Compilatio (France), Scalenut (US), Quetext (US), Sightengine (France), Sensity (Netherlands), Reality Defender (US), Attestiv (US), AI or Not (US), Facia.ai (UK), Resemble AI (US), Pindrop (US), Blackbrid.AI (US), and Perfios (India).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Fraud Analytics Market by Solution Type (Descriptive, Predictive, Prescriptive), Application (Insurance Claim, Payment Integrity), Delivery (On-premise, Cloud), End User (Government, Employers, Payers) & Region - Global Forecast to 2026
The global healthcare fraud analytics market growth is primed to transition from $1.5 billion in 2021 to $5.0 billion by 2026, showcasing a strong CAGR of 26.7%. The market is driven by the rise in fraudulent healthcare activities, an increasing number of patients seeking health insurance, and the rising number of pharmacy claims-related frauds.
- Published: October 2021
- Price: $ 4950
- TOC Available:
-
Oilfield Integrity Management Market by Management Type (Planning, Predictive Maintenance & Inspection, Corrosion Management, Data Management, and Monitoring System), Component (Hardware, Software, Services), Application, & Region - Global Forecast to 2025
The Oilfield Integrity Management Market is expected to grow from USD 12.8 billion in 2020 to USD 18.8 billion by 2025, at a CAGR of 8.1% during the forecast period. The oilfield integrity management market is dominated by a few global players, mainly from the North American region. The key players in the oilfield integrity management market include companies such as Schlumberger (US), Halliburton (US), Baker Hughes Company (US), Siemens (Germany), Emerson (US), IBM (US), and Oracle (US).
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Pipeline Integrity Market by Service (Testing, Inspection [Ultrasonic, Magnetic Flux, Caliper], Monitoring, Software), Application (Onshore, Offshore), Product (Oil, Gas, Refined Product), and Region: Global Forecast to 2024
The global pipeline integrity market is projected to reach USD 2.1 billion by 2024 from an estimated USD 1.7 billion in 2019, at a CAGR of 4.33% during the forecast period. This growth can be attributed to the huge investment pool in the pipeline business, increased government mandate and regulations for pipeline assessment, concern over environment impact, the safety of pipelines and energy infrastructure, and increased focus on the remote management of oil & gas pipeline for process optimization & automation.Rosen (Switzerland), Baker Hughes, a GE Company (US), NDT Global (Germany), T.D. Williamson (US), SGS (Switzerland), Schneider Electric (France), Emerson (US), Applus (Spain), Altus Intervention (Malaysia), Enermech (UK), Intertek (UK), IKM Gruppen (Norway), and Lin Scan (UAE).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Asset Integrity Management Market Size, Share & Industry Growth Analysis Report by Service Type (NDT, Risk-based Inspection, Corrosion Management, Pipeline Integrity, Hazard Identification, Structural Integrity Management, Reliability Availability and Maintainability) - Global Forecast to 2029
The global asset integrity management market is expected to grow from USD 23.9 billion in 2024 to USD 31.5 billion by 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period.The key players SGS Société Générale de Surveillance SA. (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), TechnipFMC plc (UK), Aker Solutions (Norway), Applus+ (Spain), DNV AS (Norway), John Wood Group PLC (UK), Oceaneering International, Inc. (US), Fluor Corporation (US), Baker Hughes Company (US).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
European Microscopy Market by Product (Optical (Fluorescence, Super-Resolution), Confocal, Electron (Transmission), Scanning (AFM)), Application (Semiconductor, Life Science, Nanotechnology), End User (Academic Institute, Industries) - Forecast to 2020
The European microscopy market is estimated to grow at a CAGR of 7.0% to reach $ 1,798.4 Million by 2020. Optical microscopy is the largest segment of the microscopy market. The electron microscopes product segment is expected to show the fastest growth during the forecast period. Key players operating in the microscopy market are Carl Zeiss (Germany), FEI Co. (U.S.), Leica Microsystems (Danaher Corp.) (U.K.) and Nikon Corporation (Japan).
- Published: May 2015
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
